Clinical Report: Ocular Surface Control in Peri-operative Dry Eye Management

Overview

This report discusses modern strategies for managing peri-operative dry eye, emphasizing the importance of ocular surface control in surgical outcomes. The role of Lacrifill® is highlighted as a supportive measure for maintaining ocular surface stability during the peri-operative period.

Background

Dry eye disease (DED) is a prevalent condition that can significantly impact surgical outcomes, particularly in cataract surgery. The TFOS DEWS III guidelines underscore the necessity of proactive management of DED to enhance patient experience and visual performance post-surgery. Understanding and addressing ocular surface health is crucial for optimizing surgical results.

Data Highlights

No specific numerical data provided in the source material.

Key Findings

• Pre-operative management of dry eye is essential for improving surgical outcomes.
• Lacrifill® plays a significant role in maintaining ocular surface stability during the peri-operative period.
• TFOS DEWS III emphasizes the need for tailored therapy based on the etiology of dry eye.
• Recent studies indicate that cataract surgery can destabilize the tear film for up to three months.
• Targeted pre-operative treatments can significantly improve tear break-up time (TBUT) and visual outcomes.

Clinical Implications

Healthcare professionals should prioritize the assessment and management of dry eye in patients undergoing cataract surgery. Implementing proactive strategies, including the use of Lacrifill®, can enhance patient comfort and surgical results.

Conclusion

Effective peri-operative dry eye management is critical for optimizing surgical outcomes in cataract patients. Adhering to established guidelines can help clinicians provide better care and improve patient experiences.

References

1. Ophthalmology Management, 2019 -- Guest Editorial
2. Contact Lens Spectrum, 2016 -- DRY EYE DX AND TX
3. The Ophthalmologist, 2026 -- Optimizing the Ocular Surface Before and After Cataract Surgery
4. TFOS DEWS III: Executive Summary - ScienceDirect
5. Glaucoma Physician — Treatment of Severe Ocular Surface Disease in the Glaucoma Patient Recommendations
6. TFOS DEWS III: Executive Summary - ScienceDirect
7. Dry eye post-cataract surgery: a systematic review and meta-analysis - PMC